tiprankstipranks
Advertisement
Advertisement

CRBP Stock Latest News

Corbus Pharmaceuticals price target lowered to $30 from $38 at Wedbush
The FlyCorbus Pharmaceuticals price target lowered to $30 from $38 at Wedbush
5d ago
CRBP
Buy Rating Reaffirmed on CRB-701’s Emerging Efficacy and Undervalued Potential; $38 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed on CRB-701’s Emerging Efficacy and Undervalued Potential; $38 Price Target Maintained
5d ago
CRBP
Corbus Pharmaceuticals share selloff overdone, says Guggenheim
PremiumThe Fly
Corbus Pharmaceuticals share selloff overdone, says Guggenheim
5d ago
CRBP
Buy Rating Reiterated on CRB-701’s Best-in-Class Potential and De-Risked Path to Registrational Trial; $40 Price Target Maintained
PremiumRatings
Buy Rating Reiterated on CRB-701’s Best-in-Class Potential and De-Risked Path to Registrational Trial; $40 Price Target Maintained
5d ago
CRBP
Corbus Highlights Promising CRB-701 Data in HPV Cancers
PremiumCompany Announcements
Corbus Highlights Promising CRB-701 Data in HPV Cancers
6d ago
8K
CRBP
Corbus Pharmaceuticals reports updated CRB-701 Phase 1/2 data
PremiumThe FlyCorbus Pharmaceuticals reports updated CRB-701 Phase 1/2 data
6d ago
CRBP
Corbus Pharmaceuticals price target raised to $44 from $40 at Mizuho
Premium
The Fly
Corbus Pharmaceuticals price target raised to $44 from $40 at Mizuho
10d ago
CRBP
Corbus Pharmaceuticals Appoints First Chief Business Officer
Premium
Company Announcements
Corbus Pharmaceuticals Appoints First Chief Business Officer
11d ago
8K
CRBP
Corbus Pharmaceuticals names Nishant Saxena as chief business officer
PremiumThe Fly
Corbus Pharmaceuticals names Nishant Saxena as chief business officer
11d ago
CRBP
Corbus Pharmaceuticals Adds Independent Director Amid Governance Updates
PremiumCompany Announcements
Corbus Pharmaceuticals Adds Independent Director Amid Governance Updates
18d ago
8K
CRBP
Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential
PremiumRatings
Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential
18d ago
CRBP
Corbus Pharmaceuticals price target lowered to $54 from $57 at Oppenheimer
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $54 from $57 at Oppenheimer
19d ago
CRBP
Corbus Pharmaceuticals price target lowered to $33 from $36 at Jefferies
PremiumThe FlyCorbus Pharmaceuticals price target lowered to $33 from $36 at Jefferies
19d ago
CRBP
Corbus Pharmaceuticals reports Q1 EPS ($1.23), consensus ($1.22)
Premium
The Fly
Corbus Pharmaceuticals reports Q1 EPS ($1.23), consensus ($1.22)
19d ago
CRBP
Corbus Highlights Oncology, Obesity Pipeline Progress and Outlook
Premium
Company Announcements
Corbus Highlights Oncology, Obesity Pipeline Progress and Outlook
20d ago
8K
CRBP
MercadoLibre, T-Mobile, Corbus, Celestica, Elevance Trending With Analysts
PremiumWeekend Updates
MercadoLibre, T-Mobile, Corbus, Celestica, Elevance Trending With Analysts
30d ago
CLS
ELV
Spotify upgraded, Alibaba initiated: Wall Street’s top analyst calls
PremiumThe Fly
Spotify upgraded, Alibaba initiated: Wall Street’s top analyst calls
1M ago
CLS
CNC
Corbus Pharmaceuticals initiated with a Buy at Guggenheim
PremiumThe Fly
Corbus Pharmaceuticals initiated with a Buy at Guggenheim
1M ago
CRBP
Corbus Pharmaceuticals Initiated at Buy on CRB-701 Head and Neck Cancer Opportunity, Undervalued Pipeline, and $45 Price Target
PremiumRatings
Corbus Pharmaceuticals Initiated at Buy on CRB-701 Head and Neck Cancer Opportunity, Undervalued Pipeline, and $45 Price Target
1M ago
CRBP
Corbus Pharmaceuticals initiated with a Buy at Guggenheim
PremiumThe FlyCorbus Pharmaceuticals initiated with a Buy at Guggenheim
1M ago
CRBP
Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections
Premium
Company Announcements
Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections
2M ago
8K
CRBP
Corbus Advances CANYON-1 Phase 1b Obesity Trial Milestone
Premium
Company Announcements
Corbus Advances CANYON-1 Phase 1b Obesity Trial Milestone
2M ago
8K
CRBP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >